KRAS and neoplasm: Some alterations induced by oncogenic KRAS mutations in cancer promote tumour cell proliferation (mitogenic effects), whereas other immune-modulatory effects allow the tumours to evade immune-mediated attack by creating an immunosuppressive microenvironment.